Publicly disclosed information about the quality of health care: response of the US public
Publicly disclosed information about the quality of health care: response of the US public
复制标题
DOI：
10.1136/qhc.10.2.96
复制
发表时间：
2001-06-01
期刊：
影响因子：
--
通讯作者：
Lieberman, T
中科院分区：
文献类型：
--
作者：
Schneider, EC;Lieberman, T
公开披露有关健康计划、医院和医生质量的信息仍然存在争议。美国过去十年的经验表明，在某些情况下，复杂的质量措施和披露质量信息的报告系统以有限的方式改善了护理过程和结果，但这些努力并没有带来所设想的“消费者选择”市场。这种失败的重要原因包括客观措施对消费者的重要性有限、解释任务的复杂性以及有组织的购买者和保险公司没有充分利用质量结果来为合同和定价决策提供信息。然而，公开披露可能会激励质量管理者和提供者进行变革，以改善护理的提供。衡量和报告质量信息的努力应保持公开，但如果它们针对机构和个人护理提供者的需求，则可能是最有效的。
Public disclosure of information about the quality of health plans, hospitals, and doctors continues to be controversial. The US experience of the past decade suggests that sophisticated quality measures and reporting systems that disclose information on quality have improved the process and outcomes of care in limited ways in some settings, but these efforts have not led to the "consumer choice" market envisaged. Important reasons for this failure include limited salience of objective measures to consumers, the complexity of the task of interpretation, and insufficient use of quality results by organised purchasers and insurers to inform contracting and pricing decisions. Nevertheless, public disclosure may motivate quality managers and providers to undertake changes that improve the delivery of care. Efforts to measure and report information about quality should remain public, but may be most effective if they are targeted to the needs of institutional and individual providers of care.